Navigation Links
The Palomino Group Announces Launch of Meeting Support Services Business Unit
Date:7/24/2008

The Palomino Group, a leading commercialization and reimbursement services organization, today announced the launch of its new Meeting Support Services business unit targeted to the biopharmaceutical industry. The company, based in Minneapolis, MN offers comprehensive reimbursement and commercialization consulting services that support biotechnology, pharmaceutical, medical device, and other healthcare companies.

Minneapolis, MN (PRWEB) July 24, 2008 -- The Palomino Group, a leading commercialization and reimbursement services organization, today announced the launch of its new Meeting Support Services business unit targeted to the biopharmaceutical industry. The company, based in Minneapolis, MN offers comprehensive reimbursement and commercialization consulting services that support biotechnology, pharmaceutical, medical device, and other healthcare companies.

The Palomino Group has continued to diversify the types of services and support that it offers to meet the growing needs of biopharmaceutical client companies. Since launching the company's commercialization and reimbursement consulting business, the Palomino Group has significantly expanded its business opportunities and currently supports numerous biopharmaceutical products in the pre-launch development, launch, and post-launch commercial settings.

"In view of the current environment and the projected landscape within the biopharmaceutical arena over the next few years, there is an expanding need for commercialization and reimbursement consulting services within the marketplace," said Charles Griffin, Co-Founder and Principal of the Palomino Group. "We believe that the launch of our new Meeting Support Services business unit is a natural evolution of our current capabilities and consulting service offerings to current and future client customers. Our clients are increasingly outsourcing capabilities to support these types of clinical and commercial needs, and are seeking consulting groups that possess a comprehensive understanding of all of these critical capabilities."

Under the Meeting Support Services umbrella, the Palomino Group will offer client companies a full menu of meeting and program services to allow for the execution of high quality clinical and scientific advisory boards, investigator meetings, symposia, reimbursement and managed markets advisory sessions, and other clinical, scientific, and commercial programs. "We are finding that the healthcare arena has evolved to the point where there is significant integration and overlap of clinical, commercial, and payer considerations. Manufacturers are seeking consultant experts that understand these critical issues and points of integration in order to better develop strategies and programs that are more closely aligned with issues impacting key thought leaders, policy makers, and the healthcare marketplace," said Jan Palmer, Co-Founder and Principal of the Palomino Group.

In addition to its new Meeting Support Services, the Palomino Group offers a variety of Reimbursement and Commercialization consulting support services, including:

  • Strategic Reimbursement Analyses
  • Market Assessments
  • Product Coverage Introductions
  • Payer Advocacy
  • Coding and Pricing Support
  • Legislative and Policy Monitoring
  • Qualitative Reimbursement Research    
  • Managed Markets Development
  • Strategic Market Planning
  • Launch Plan Development
  • Pricing & Contracting Strategy
  • Strategic Life Cycle Development
  • Commercial Operation Design & Budgeting

About The Palomino Group
The Palomino Group (The Palomino Group Health Care Consultants, LLC) is a leading service provider that offers commercialization and reimbursement consulting services to biotechnology, pharmaceutical, medical device, and other healthcare companies. Based in Minneapolis, the company works with client healthcare companies to provide expert commercialization and reimbursement support services for new and existing drugs, biologics, and healthcare technologies. The company is heavily focused within oncology and other key disease arenas. Additional information about the Palomino Group is available on their website at http://www.palominogroup.com.

Minneapolis Corporate Headquarters:
Main: 763.444.6525
info @ palominogroup.com
25248 Lincoln Drive
Isanti, MN 55040

###

Read the full story at http://www.prweb.com/releases/2008/07/prweb1134704.htm


'/>"/>
Source: PRWeb
Copyright©2008 Vocus, Inc.
All rights reserved

Related medicine news :

1. Greater Medical Center Group Receives Major Funding From MELCO Investments
2. Cowen Healthcare Royalty Partners and Cowen Group, Inc. Announce Closing of Fund
3. Sweet Dreams, Sweet Breath: MedGen Inc. Retains TransMedia Group to Send Media a Wake-Up Call About an All-Natural, Quick New Way to Slumber Land
4. Consumer Groups File Appeal on Challenge of Human Stem Cell Patent Held By WARF
5. Baxa Corporation Launches New Electronic Users Group Web Site
6. Lucas Group Celebrates Its 38th Anniversary
7. Alta Bates Medical Group (ABMG) Teams With Illumisys, LLC to Promote Quality of Care to Patients and Increase Adoption and Use of Health Information Technologies.
8. The Quantum Group Files TPA Application
9. Broadlane's Live Group Buy Awards High-Field Open MRI Contract to Hitachi Medical Systems America Inc.
10. Lucas Group to Host Military Hiring Conferences in Washington, DC; Irvine, CA and Dallas, TX
11. Lincoln Financial Group Announces New Dental Panel of Providers
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/5/2016)... ... December 05, 2016 , ... ... and relationship-marketing firm, announced today that nominations will be accepted from December ... (ISE®) Central Awards. , Awards include the Information Security Executive® of the ...
(Date:12/5/2016)... ... December 05, 2016 , ... ... Meeting through tomorrow, December 6th, sparks a conversation about epilepsy, bearing down on ... in 26 people will be diagnosed with epilepsy within their lifetime. With such ...
(Date:12/5/2016)... , ... December 05, 2016 ... ... interoperability, today announced that the company will provide alerting technology to Central ... been recently awarded $1.7 million in federal funds as the sole sub-recipient ...
(Date:12/5/2016)... ... December 05, 2016 , ... Dr. Barry M. Weintraub, one ... Surgery, who recently participated in the 36th Annual Cutting Edge Aesthetic Symposium at the ... techniques for getting that perfect, yet natural-looking, nose. Dr. Weintraub, who is world-renowned for ...
(Date:12/5/2016)... , ... December 05, 2016 , ... ... Officer for the Florida Hospital West Florida Region. McGuinness brings experience in executive ... and engaging staff, physicians and leaders. , In her new role, that officially ...
Breaking Medicine News(10 mins):
(Date:12/5/2016)... , Dec. 5, 2016  BD (Becton, Dickinson ... global medical technology company, will demonstrate an enhanced technology ... management technologies, including the company,s leading Pyxis™ and Alaris™ ... Pharmacists (ASHP) 2016 Midyear Meeting being held in ... While national data show that approximately 68 ...
(Date:12/5/2016)... Research and Markets has announced the addition of the "Global ... and Demand Forecast to 2022" report to their offering. ... , , ... market is expected to grow at a CAGR of 4.5% during ... witnessing high growth, due to growing female geriatric population and increasing ...
(Date:12/5/2016)... England , December 5, 2016 ... Transitions to Deputy Chairman   ... on selectively targeting deubiquitylating enzymes (DUBs) to treat cancer, neurodegenerative ... has been appointed as non-executive Chairman, effective January 1 st ... of Mission Therapeutics as a non-executive Director in July 2015. ...
Breaking Medicine Technology: